Coats Lonnel's Form 4 filing
Lexicon Pharmaceuticals, Inc.LXRX · filed Nov 17, 2023
- Accession no.
- 0001127602-23-027850
- Filed
- Nov 17, 2023
- Trade date
- Nov 16, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $94.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coats LonnelCIK 0001612528 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +90,000 | $1.05F1 | +$94,500 | 914,359 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $1.05 to $1.06 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Coats hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
Referenced by the price of 1 transaction in Table I.